Stockholm
18-64 years old
Blood sample studies, Healthy individualsStudy 1016
We are looking for healthy individuals for a method development study.
In the study, white blood cells are collected using a standardized method called leukapheresis. The purpose of the study is to develop new treatment methods that could potentially be used in future cancer treatments.
Target group: healthy individuals, 18–64 years old
Criteria for participation:
- Be healthy
- Not be treated with medications that affect the immune system or the blood's ability to clot
- Not have, or have a history of, bleeding disorders
The study consists of two visits. The first visit is a health check-up at our clinic in Solna. The second visit takes place at OptiCell Solutions in Huddinge, where you will provide blood from one arm via an intravenous catheter (a small plastic tube in the vein). The blood is centrifuged, separated, and most of it is returned to your body through an intravenous catheter in the other arm. In total, you will provide 150 ml of blood cells. This visit is estimated to take approximately three hours.
Compensation:
SEK 1950 in compensation for your participation.
Available times:
| Visit 1 | Visit 2 |
| Times will be announced as they become available |
More information and registration
Would you like to participate in the study? Submit an expression of interest using the form below.
Do you have questions or want to know more? Call 018-30 33 99 or email info@ctc-ab.se.
The study has been approved by the Ethical Review Authority. Your participation is voluntary, and you can withdraw at any time. The information you provide will be processed in accordance with the General Data Protection Regulation (GDPR).
